Dextromethorphan/Bupropion Tablet AXS-05 clinical trials
Also written AXS-05.
How each study uses Dextromethorphan/Bupropion Tablet AXS-05 is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the Dextromethorphan/Bupropion Tablet AXS-05 studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
16 studies that test it; most in 2020 (3)
| Year | Studies |
|---|---|
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 2 |
| 2020 | 3 |
| 2021 | 2 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 1 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 14 · Other 2
Axsome Therapeutics, Inc. (14) · James Davis (1) · Roger McIntyre (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses Dextromethorphan/Bupropion Tablet AXS-05 is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 16
- Studying NMDA and Sigma-1 in Smoking Cessation Treatment (SUMMIT)RecruitingPhase 3Axsome Therapeutics, Inc.NCT07766655Written as AXS-05 (dextromethorphan-bupropion)
- Dextromethorphan-Bupropion on Striatal Activity in Adults With Major Depressive DisorderRecruitingPhase 2Roger McIntyreNCT07523048Written as Dextromethorphan-Bupropion
- A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive SymptomsRecruitingPhase 4Axsome Therapeutics, Inc.NCT06223880Written as AXS-05
- A Study to Assess the Efficacy and Safety of AXS-05 in Subjects With Alzheimer's Disease AgitationCompletedPhase 3Axsome Therapeutics, Inc.NCT05557409Written as AXS-05
- An Open-Label Study to Assess the Long-term Safety of AXS-05 in Subjects With Dementia of the Alzheimer's Type, ADVANCE-2 and ACCORD-2 Extension StudyTerminatedPhase 3Axsome Therapeutics, Inc.NCT06736509Written as AXS-05 (dextromethorphan-bupropion)
- Open-Label Safety Study of AXS-05 in Subjects With TRD (EVOLVE)TerminatedPhase 2Axsome Therapeutics, Inc.NCT04634669Written as AXS-05 (dextromethorphan-bupropion)
- A Study to Assess the Long-term Safety and Efficacy of AXS-05 in Subjects With Alzheimer's Disease AgitationCompletedPhase 3Axsome Therapeutics, Inc.NCT04947553Written as AXS-05 (dextromethorphan-bupropion)
- Assessing Clinical Outcomes in Alzheimer's Disease AgitationCompletedPhase 3Axsome Therapeutics, Inc.NCT04797715Written as AXS-05
- Addressing Dementia Via Agitation-Centered EvaluationCompletedPhase 2/3Axsome Therapeutics, Inc.NCT03226522Written as AXS-05
- AXS-05 Phase II Trial on Smoking BehaviorCompletedPhase 2James DavisNCT03471767Written as AXS-05
- A Trial of AXS-05 in Patients With Major Depressive DisorderCompletedPhase 3Axsome Therapeutics, Inc.NCT04019704Written as AXS-05
- Open-Label Safety Study of AXS-05 in Subjects With DepressionCompletedPhase 3Axsome Therapeutics, Inc.NCT04039022Written as AXS-05 (dextromethorphan and bupropion) oral tablets
- Mechanistic Evaluation of Response in TRD (MERIT)CompletedPhase 2Axsome Therapeutics, Inc.NCT04608396Written as AXS-05
- Assessing Symptomatic Clinical Episodes in DepressionCompletedPhase 2Axsome Therapeutics, Inc.NCT03595579Written as AXS-05
- An Evaluation of AXS-05 for the Treatment of TRD in Treatment-Adherent PatientsStatus unknownPhase 2Axsome Therapeutics, Inc.NCT04971291Written as AXS-05
- A Study to Assess the Efficacy and Safety of AXS-05 in Subjects With Treatment Resistant Major Depressive DisorderCompletedPhase 3Axsome Therapeutics, Inc.NCT02741791Written as AXS-05